Table 2.
Comorbidities, demographics, average lab values, average length of stay and projected mortality among COVID-19 patients, in aggregate and broken down into mild/severe patients
| Feature | All Patients | Mild Patients | Severe Patients | |||||
|---|---|---|---|---|---|---|---|---|
| No. Report | Avg. | No. Report. | Avg. | No. Report. | Avg. | |||
| Demographics | ||||||||
| Male (%) | 131,200 | 53.0% | 9,570 | 48.8% | 10,120 | 68.7% | ||
| Age (years) | 119,000 | 51.3 | 8,022 | 46.1 | 9,685 | 68.2 | ||
| White/European (%) | 55,490 | 22.2% | 10,120 | 9.7% | 9,887 | 63.9% | ||
| African American (%) | 55,490 | 5.4% | 10,120 | 3.5% | 9,887 | 2.5% | ||
| Asian (%) | 55,320 | 51.3% | 10,300 | 80.2% | 9,933 | 31.2% | ||
| Hispanic/Latino | 50,630 | 19.9% | 8,017 | 0% | 9,107 | 0% | ||
| Multiple ethnicities/other | 55,190 | 3.6% | 10,120 | 6.9% | 9,887 | 2.7% | ||
| Comorbidities | ||||||||
| Smoking history | 27,900 | 16.1% | 6,080 | 12.2% | 1,973 | 16.6% | ||
| Hypertension | 38,390 | 35.9% | 8,252 | 15.2% | 8,449 | 54.4% | ||
| Diabetes | 39,790 | 20.8% | 8,396 | 6.8% | 8,818 | 26.1% | ||
| Cardio Disease | 40,030 | 12.4% | 8,028 | 3.0% | 9,540 | 20.3% | ||
| COPD | 34,150 | 6.0% | 6,297 | 2.8% | 8,727 | 10.0% | ||
| Cancer | 29,170 | 7.2% | 6,259 | 3.2% | 8,355 | 12.9% | ||
| Liver Disease | 18,300 | 2.8% | 1,875 | 2.3% | 6,832 | 3.5% | ||
| Cebrovascular | 6,830 | 9.8% | 3,245 | 2.7% | 1,360 | 24.8% | ||
| Kidney Disease | 35,500 | 5.7% | 6,152 | 1.2% | 8,139 | 10.8% | ||
| Lab values | ||||||||
| WBC Count (109/L) | 19,970 | 6.41 | 5,403 | 5.07 | 2,305 | 6.80 | ||
| Neutrophil Count (109/L) | 12,500 | 4.72 | 2,236 | 5.12 | 1,410 | 5.78 | ||
| Platelet Count (109/L) | 12,125 | 195.7 | 5,165 | 184.0 | 2,105 | 170.4 | ||
| ALT (U/L) | 14,467 | 29.0 | 2,840 | 24.6 | 2,428 | 31.1 | ||
| AST (U/L) | 14,214 | 37.3 | 2,766 | 27.1 | 2,366 | 45.7 | ||
| BUN (mmol/L) | 4,822 | 5.22 | 1,700 | 4.18 | 1,138 | 6.86 | ||
| Creatinine (μ mol/L) | 8,504 | 63.08 | 2,529 | 66.0 | 2,454 | 56.4 | ||
| CRP Count (mg/L) | 17,090 | 76.5 | 2,573 | 18.9 | 2,339 | 94.1 | ||
| Interleukin-6 (pg/mL) | 2,582 | 24.57 | 1,127 | 4.17 | 552 | 38.63 | ||
| Procalcitonin (ng/mL) | 14,750 | 2.26 | 1,468 | 1.85 | 1,969 | 4.81 | ||
| D-Dimer (mg/L) | 13,330 | 38.81 | 2,478 | 8.04 | 2,401 | 165.9 | ||
| Length of Stay (days) | 16,010 | 10.7 | 4,131 | 14.0 | 5,642 | 7.97 | ||
| Proj. Mortality (%) | 111,700 | 11.7% | 7,428 | 0.4% | 9,146 | 74.0% | ||